Updated:
Biotech Alliances International
Biotech Alliances International is a San Francisco-based investment bank focused on life sciences companies and private equity and venture capital funds.
Biotech Alliances International
Biotech Alliances International is a San Francisco-based investment bank focused on life sciences companies and private equity and venture capital funds. The firm provides financial and strategic advice on corporate finance, mergers & acquisitions, partnering & licensing, deal sourcing, and strategic consulting. Biotech Alliances International has made two investments, including a Series D investment in EpicentRx on November 13, 2019.
General information
Firm type
Life Science Advisory
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
How does Biotech Alliances International source its investment opportunities?
The firm leverages its San Francisco location to build relationships with academic technology transfer offices, venture-backed biotech founders, and life science accelerators. Its sourcing model emphasizes early identification of platform technologies — such as AI-driven drug discovery engines — that can be scaled through Asian clinical capabilities and commercial channels. The firm's principals are understood to maintain direct relationships with key opinion leaders at UCSF, Stanford, and Berkeley.
Which therapeutic areas does Biotech Alliances International prioritize?
The firm targets platform technologies with broad applicability rather than single-indication plays. Known areas of focus include computational chemistry for small-molecule screening, AI-enabled medical imaging diagnostics, and digital biomarkers for neurodegenerative diseases. Oncology and autoimmune programs have historically attracted the most cross-border alliance interest.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: